Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

Por Moore, David F, Altarescu, Gheona, Herscovitch, Peter, Schiffmann, Raphael
Publicado em 2002

Clinical Use of Diffusion-Tensor Imaging for Diseases Causing Neuronal and Axonal Damage

Por Uluğ, Aziz M., Moore, David F., Bojko, Aviva S., Zimmerman, Robert D.
Publicado no AJNR Am J Neuroradiol (1999)

Hepatitis C and recurrent treatment-resistant acute ischemic stroke

Por Saxsena, Aneeta, Tarsia, Joseph, Dunn, Casey, Aysenne, Aimee, Shah, Basil, Moore, David F.
Publicado em 2013

Arterial Wall Properties and Womersley Flow in Fabry Disease

Por Moore, David F, Altarescu, Gheona, Pursley, Randall, Campia, Umberto, Panza, Julio A, Dimitriadis, Emilios, Schiffmann, Raphael
Publicado em 2002

An animal-to-human scaling law for blast-induced traumatic brain injury risk assessment

Por Jean, Aurélie, Nyein, Michelle K., Zheng, James Q., Moore, David F., Joannopoulos, John D., Radovitzky, Raúl
Publicado em 2014

Enhanced Endothelium-Dependent Vasodilation in Fabry Disease

Por Altarescu, Gheona, Moore, David F., Pursley, Randall, Campia, Umberto, Goldstein, Seth, Bryant, Melissa, Panza, Julio A., Schiffmann, Raphael
Publicado no Stroke (2001)

Reply to Moss et al.: Military and medically relevant models of blast-induced traumatic brain injury vs. ellipsoidal heads and helmets

Por Nyein, Michelle K., Jason, Amanda M., Yu, Li, Pita, Claudio M., Joannopoulos, John D., Moore, David F., Radovitzky, Raul
Publicado em 2011

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells

Por Shen, Jin-Song, Meng, Xing-Li, Moore, David F., Quirk, Jane M., Shayman, James A., Schiffmann, Raphael, Kaneski, Christine R.
Publicado em 2008

In silico investigation of intracranial blast mitigation with relevance to military traumatic brain injury

Por Nyein, Michelle K., Jason, Amanda M., Yu, Li, Pita, Claudio M., Joannopoulos, John D., Moore, David F., Radovitzky, Raul A.
Publicado em 2010

Skin-impedance in Fabry Disease: A prospective, controlled, non-randomized clinical study

Por Gupta, Surya N, Ries, Markus, Murray, Gary J, Quirk, Jane M, Brady, Roscoe O, Lidicker, Jeffrey R, Schiffmann, Raphael, Moore, David F
Publicado em 2008

Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalities

Por Moore, David F., Krokhin, Oleg V., Beavis, Ronald C., Ries, Markus, Robinson, Chevalia, Goldin, Ehud, Brady, Roscoe O., Wilkins, John A., Schiffmann, Raphael
Publicado em 2007

Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach

Por Moore, David F., Gelderman, Monique P., Ferreira, Paulo A., Fuhrmann, Steven R., Yi, Haiqing, Elkahloun, Abdel, Lix, Lisa M., Brady, Roscoe O., Schiffmann, Raphael, Goldin, Ehud
Publicado em 2007

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy?

Por Kateb, Babak, Chiu, Katherine, Black, Keith L., Yamamoto, Vicky, Khalsa, Bhavraj, Ljubimova, Julia Y., Ding, Hui, Patil, Rameshwar, Portilla-Arias, Jose Antonio, Modo, Mike, Moore, David F., Farahani, Keyvan, Okun, Michael S., Prakash, Neal, Neman, Josh, Ahdoot, Daniel, Grundfest, Warren, Nikzad, Shouleh, Heiss, John D.
Publicado em 2010